Edgewise Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025

Published: 2025-05-08 08:05:00 ET EWTX

Published on 05/08/2025 at 08:05, updated on 05/08/2025 at 09:35

Edgewise Therapeutics, Inc. reported earnings results for the first quarter ended March 31, 2025. For the first quarter, the company reported net loss was USD 40.8 million compared to USD 28.53 million a year ago. Basic loss per share from continuing operations was USD 0.43 compared to USD 0.33 a year ago.

Diluted loss per share from continuing operations was USD 0.43 compared to USD 0.33 a year ago.